Allmed Solutions Ltd
TASE:ALMD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
30
46.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches ILS.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Allmed Solutions Ltd
Net Issuance of Debt
Allmed Solutions Ltd
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Allmed Solutions Ltd
TASE:ALMD
|
Net Issuance of Debt
-₪288k
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
InspireMD Inc
NASDAQ:NSPR
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
Nissan Medical Industries Ltd
TASE:NISA
|
Net Issuance of Debt
-₪64.4m
|
CAGR 3-Years
-70%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Allmed Solutions Ltd
Glance View
Allmed Solutions Ltd. engages in the development, manufacture, and marketing of minimally invasive products internationally in various medical disciplines. Its products are used by physicians to treat a number of diseases and patients worldwide. The firm's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The firm's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.
See Also
What is Allmed Solutions Ltd's Net Issuance of Debt?
Net Issuance of Debt
-288k
ILS
Based on the financial report for Dec 31, 2023, Allmed Solutions Ltd's Net Issuance of Debt amounts to -288k ILS.
What is Allmed Solutions Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 3Y
38%
Over the last year, the Net Issuance of Debt growth was 23%. The average annual Net Issuance of Debt growth rates for Allmed Solutions Ltd have been 38% over the past three years .
You don't have any saved screeners yet
